Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of East West Bancorp's 2026 Annual Meeting of Stockholders held on May 18, 2026. The filing presents voting results for five proposals: election of eleven directors, advisory vote on executive compensation, amendment and restatement of the 2021 Stock Incentive Plan, adoption of the 2026 Employee Stock Purchase Plan, and ratification of KPMG LLP as independent auditors. All proposals passed with substantial majorities (ranging from 95.18% to 99.92% of votes cast), and the disclosure includes detailed vote tallies for each matter as required by SEC rules.
View raw filing on EDGAR →
Dilutive issuance
confidence 75%
filed 2026-05-19
Item 5.02
The Board approved debt-to-equity conversion agreements with four creditors (including the CEO and VP Administration) whereby the Company will issue 1,509,710 common shares in aggregate to settle approximately C$1.24 million in deferred management fees. This is a dilutive issuance of equity securities to settle debt, subject to regulatory approvals and shareholder vote. While technically a debt settlement, the core disclosure centers on the issuance of a substantial number of shares to insiders, which is material to investors assessing ownership dilution and related-party transactions.
View raw filing on EDGAR →
Exec Compensation
confidence 75%
filed 2026-05-19
Item 7.01
The filing discloses a grant of 100,000 stock options to an officer on May 18, 2026, exercisable at C$0.82 per share for five years, made pursuant to the Company's Long-Term Incentive Plan. This is a direct compensatory arrangement for a named executive and constitutes a material equity grant that would affect investor assessment of executive compensation and potential dilution.
View raw filing on EDGAR →
Dilutive issuance
confidence 85%
filed 2026-05-19
Item 1.01
The Company amended preferred investment options with Armistice Capital, dramatically reducing the exercise price from $16.60 to $0.80 per share on 278,761 common shares. This substantial downward repricing of equity warrants significantly increases the likelihood of exercise and dilution to existing shareholders, making it a material dilutive event. The amendment effectively converts out-of-the-money options into deeply in-the-money instruments, which is a classic signal of dilutive equity issuance activity.
View raw filing on EDGAR →
Other material
confidence 45%
filed 2026-05-19
Item 3.03
Item 3.03 discloses a material modification to security holders' rights and incorporates Item 1.01 by reference. Item 1.01 typically covers entry into a material agreement or plan of acquisition, merger, or disposition. Without access to the full Item 1.01 content, the specific nature of the modification cannot be determined; however, the cross-reference signals a material event affecting shareholder rights that does not fit neatly into the more specific event categories (e.g., it may involve a restructuring, recapitalization, or other corporate action).
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-19
Item 8.01
The filing discloses an amendment to the "Armistice Preferred Investment Options" announced via press release on May 19, 2026. While the specific terms and materiality of the amendment are not detailed in the Item 8.01 text itself, amendments to preferred investment arrangements with a named counterparty (Armistice) typically signal a material modification to the company's capital structure or financing terms. Without clearer language indicating this is a routine administrative matter, and given the formal press release announcement, this is classified as a material event that does not fit neatly into more specific categories (e.g., not a dilutive issuance, not M&A, not compensation).
View raw filing on EDGAR →
M&A activity
confidence 92%
filed 2026-05-19
Item 8.01
HIVE Digital's wholly owned subsidiary BUZZ High Performance Computing completed the acquisition of two parcels of land totaling $58 million ($46 million for the Main Parcel and $12 million for the Additional Parcel) with a combined 320 MW power allocation. This represents a material acquisition of real property and infrastructure assets that would be significant to investors evaluating the company's capital deployment and operational expansion strategy.
View raw filing on EDGAR →
Other material
confidence 75%
filed 2026-05-19
Item 8.01
American Tower Corporation announced the pricing of a €750 million registered public offering of senior unsecured notes due 2033 at 4.000% per annum. This is a material debt issuance that would affect investor assessment of the company's capital structure and financing activities, but it does not fit neatly into the more specific event categories (it is neither a dilutive equity issuance under Item 3.02, nor an M&A activity, nor a covenant breach). The disclosure is appropriately classified as other_material.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This Item 5.07 filing discloses the results of Amkor Technology's Annual Meeting of Stockholders held on May 13, 2026, including voting outcomes on three proposals: election of 11 directors, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from YUM! Brands' Annual Meeting of Shareholders held on May 14, 2026, filed under Item 5.07. The filing reports voting outcomes on four matters: election of 11 directors, ratification of KPMG LLP as independent auditor, advisory vote on executive compensation, and a shareholder proposal on special meeting thresholds. All vote tallies (for, against, abstain, broker non-votes) are provided for each matter, which is the standard format for Item 5.07 disclosures.
View raw filing on EDGAR →
Exec Compensation
confidence 95%
filed 2026-05-19
Item 5.02
This disclosure describes stockholder approval of an amendment to the 2012 Equity Incentive Plan increasing the share reserve by 5,000,000 shares. This is a compensatory arrangement amendment affecting equity grants available to officers and directors, which falls squarely within the exec_compensation category. The materiality is high given the substantial increase in authorized equity and its impact on future dilution and executive compensation capacity.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder voting results from FormFactor's Annual Meeting held May 15, 2026, covering five proposals: director elections, certificate amendment, executive compensation advisory vote, equity plan amendment, and auditor ratification. The detailed vote tallies and approval outcomes are the core content of Item 5.07, which is the standard vehicle for reporting shareholder meeting results. The election of all seven directors and approval of material proposals (equity plan increase, compensation) are material to investors.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder voting results from Celestica Inc.'s 2026 annual meeting held on May 19, 2026. The filing reports final voting tallies on three matters: election of nine directors, approval of auditor appointment, and an advisory vote on named executive officer compensation. The Item 5.07 classification and detailed vote counts for each matter are unmistakable indicators of shareholder vote results.
View raw filing on EDGAR →
Shareholder vote
confidence 95%
filed 2026-05-19
Item 8.01
The filing explicitly discloses "voting results from the Meeting" announced via press release on May 19, 2026. This is a direct disclosure of shareholder vote outcomes, which is material to investors as it reflects approval or rejection of corporate actions. Although filed under Item 8.01 (Other Events), the substance clearly indicates shareholder_vote_results per Item 5.07.
View raw filing on EDGAR →
Exec departure
confidence 75%
filed 2026-05-19
Item 5.02
David L. Duvall, the Company's President and Chief Executive Officer, is transitioning out of his executive role effective June 1, 2026, under a Transition Agreement. While the agreement includes a consulting arrangement with compensatory terms ($50,000 monthly fee through December 31, 2027), the principal disclosed action is the departure of the CEO from his operational role. The departure of a sitting CEO is material to investors assessing management continuity and company direction.
View raw filing on EDGAR →
Earnings release
confidence 98%
filed 2026-05-19
Item 2.02
The filing discloses financial results for the quarter and fiscal year ended March 31, 2026 through a press release and stockholder letter with financial highlights, furnished as exhibits. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides quarterly and annual financial performance information.
View raw filing on EDGAR →
Other material
confidence 72%
filed 2026-05-19
Item 8.01
FB Bancorp completed a stock repurchase program that retired 10% of outstanding shares at an average price of $13.717 per share. While share repurchases are capital allocation events that affect shareholder equity and EPS, they do not fit neatly into the more specific event categories (not an earnings release, M&A, impairment, or executive change). This is material to investors as it reflects management's capital deployment strategy and impacts share count, but lacks a dedicated taxonomy entry.
View raw filing on EDGAR →
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The Board approved and adopted an Amended and Restated Annual Incentive Plan on May 13, 2026, making administrative and technical updates to the compensation plan structure. This is a compensatory arrangement disclosure under Item 5.02(e), involving amendments to a bonus incentive plan that affects how participating employees—including Named Executive Officers—receive performance-based compensation. The amendments clarify delegation authority and align the plan with the 2025 Stock Incentive Plan.
View raw filing on EDGAR →
Exec departure
confidence 85%
filed 2026-05-19
Item 5.02
Richard H. Raborn, Executive Vice President of the Vegetation Management Division, is retiring effective May 29, 2026. While the disclosure also includes severance terms (base salary of $536,000 paid over 12 months), the principal disclosed action is the departure itself. The filing emphasizes the retirement and separation, making exec_departure the most salient classification, though the compensation component is secondary.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Shareholders held on May 19, 2026. The filing reports voting outcomes for three proposals: election of seven directors, advisory vote on named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Bausch Health's Annual Meeting of Shareholders held on May 19, 2026. The filing reports voting outcomes on three proposals: election of directors (including new director Eiry W. Roberts, M.D.), advisory vote on executive compensation, and appointment of PricewaterhouseCoopers LLP as auditors. This is a quintessential Item 5.07 disclosure with detailed voting tallies for each matter.
View raw filing on EDGAR →
Exec Compensation
confidence 92%
filed 2026-05-19
Item 5.02
The disclosure centers on shareholder approval of two equity compensation plans (the 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan) and the Board's approval of a Restricted Stock Unit Award Agreement for directors. These are compensatory arrangements for officers and directors, making this an exec_compensation event rather than a routine governance matter.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder voting results from Merit Medical Systems' Annual Meeting held on May 13, 2026. The filing reports detailed vote tallies for five proposals: election of four directors, advisory say-on-pay vote, approval of two equity plans, and ratification of the independent auditor. This is a quintessential Item 5.07 disclosure and is material to investors as it documents shareholder approval of governance and compensation matters.
View raw filing on EDGAR →
Exec appointment
confidence 95%
filed 2026-05-19
Item 7.01
The disclosure announces the election of Scott R. Ward as a director of Merit Medical Systems Inc. This is a clear executive appointment event. Director elections are material to investors as they affect board composition and governance, and the company chose to disclose this via press release on Form 8-K Item 7.01, indicating materiality.
View raw filing on EDGAR →
Dilutive issuance
confidence 85%
filed 2026-05-19
Item 8.01
Farmer Mac completed an issuance of 4,000,000 shares of preferred stock in an exempt public offering on May 19, 2026. While this is a preferred stock issuance rather than common equity, it represents a material capital raise that dilutes existing shareholders' ownership and is typically disclosed under Item 3.02 (Unregistered Sales) or Item 8.01 (Other Events). The issuance of 4 million shares of preferred stock with a stated dividend rate (6.875%) is material to investors assessing the company's capital structure and financing activities.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from WSFS Financial Corporation's 2026 Annual Meeting held on May 14, 2026. The filing reports voting outcomes on three proposals: election of three directors (Eleuthère I. du Pont, Michelle Hong, and David G. Turner), advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the hallmark of Item 5.07 shareholder vote disclosures.
View raw filing on EDGAR →
Exec Compensation
confidence 95%
filed 2026-05-19
Item 5.02
This disclosure reports stockholder approval of an amendment to the Teradata 2023 Stock Incentive Plan that increases available shares by 6,300,000 shares. This is a compensatory arrangement amendment requiring shareholder approval under Item 5.02(e), directly affecting the equity compensation pool available for officers and directors. The material increase in share authorization makes this material to investors assessing dilution and executive compensation capacity.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder vote results from Teradata's Annual Meeting of Stockholders held on May 14, 2026. The filing reports voting outcomes on four matters: election of three Class I directors (Melissa B. Fisher, Stephen McMillan, and Kimberly K. Nelson), an advisory say-on-pay vote, approval of the Amended 2023 Plan, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (for, against, abstain, broker non-votes) for each proposal are the core disclosure required under Item 5.07.
View raw filing on EDGAR →
Exec Compensation
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses compensatory arrangements for three named executive officers: salary increases (ranging from $9,100 to $11,024) and equity awards of 500 immediately-vesting restricted shares each, approved by the Compensation Committee on May 14, 2026. This is a direct disclosure of executive compensation modifications under Item 5.02(e), distinct from any departure or appointment.
View raw filing on EDGAR →
Earnings release
confidence 98%
filed 2026-05-19
Item 2.02
The filing discloses results of operations for the three-month and six-month periods ended April 30, 2026 via a press release attached as Exhibit 99.1, which is the classic structure of an earnings release under Item 2.02. This is material to investors as it provides periodic financial performance data essential to assessing the registrant's financial condition and results.
View raw filing on EDGAR →
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses both a director retirement (Gary Lehman) and a director appointment (Paul Fultz). While both events are mentioned, the appointment is the principal forward-looking action: Fultz was appointed to fill the vacancy and will serve on the Audit Committee. The explicit statement that Lehman's retirement "is not the result of any disagreement" suggests a routine transition, making the appointment the more salient event. Director changes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
Earnings release
confidence 98%
filed 2026-05-19
Item 2.02
The Company issued a press release on May 19, 2026 announcing financial results for the fiscal quarter ended May 3, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release disclosure, which is material to investors as it provides key financial performance metrics and operational results.
View raw filing on EDGAR →
Exec appointment
confidence 85%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Thomas Dittrich as Executive Vice President and Chief Financial Officer effective September 1, 2026, along with detailed compensation arrangements including base salary (CHF 1,070,000), equity grants (CHF 4,500,000 target), sign-on RSU award (CHF 4,700,000), and retention bonus (CHF 5,800,000). While the section also mentions Peter Griffith's retirement, the substantive focus and length of disclosure centers on Dittrich's appointment and his comprehensive compensation package, making this primarily an exec_appointment event. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance.
View raw filing on EDGAR →
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Carrie Anderson as Executive Vice President and Chief Financial Officer effective July 1, 2026, succeeding retiring Charles T. Lauber. While the section also mentions Lauber's retirement, the principal disclosed action centers on Anderson's appointment to a C-suite role, supported by detailed background, compensation terms ($1.5M RSU award), and benefit arrangements. This is a material executive appointment at a major industrial company.
View raw filing on EDGAR →
Exec appointment
confidence 95%
filed 2026-05-19
Item 5.02
The filing discloses the appointment of Ali El-Haj as President, Chief Executive Officer, and Director of Rogers Corporation, effective immediately on May 19, 2026. While the offer letter includes compensation details (base salary of $750,000, target incentive of 100% of base, and a $5,000,000 long-term equity grant), the principal disclosed action is the appointment itself—El-Haj's transition from Interim President and CEO to permanent President, CEO, and Board member. This is a material executive appointment that would affect a reasonable investor's assessment of the company's leadership.
View raw filing on EDGAR →
Exec appointment
confidence 95%
filed 2026-05-19
Item 8.01
The filing discloses the appointment of Mr. El-Haj to the positions of President, Chief Executive Officer, and Director. This is a material executive appointment involving the company's top leadership roles. Although disclosed under Item 8.01 (Other Events), the substance is clearly an executive appointment rather than a routine administrative matter.
View raw filing on EDGAR →
M&A activity
confidence 75%
filed 2026-05-19
Item 1.01
Humana Inc. entered into material definitive agreements on May 15, 2026, establishing a $1.5 billion pre-capitalized trust securities facility with two trusts (Horseshoe Funding Trust I and II) that provides on-demand capital and liquidity through the issuance of up to $750 million in Senior Notes to each trust over extended periods (10 and 30 years respectively). While this is technically a financing arrangement rather than a traditional M&A transaction, it represents a material capital structure transaction involving the entry into multiple definitive agreements with significant financial implications, fitting the substance of Item 1.01 disclosure requirements for material definitive agreements.
View raw filing on EDGAR →
Other material
confidence 45%
filed 2026-05-19
Item 2.03
Item 2.03 discloses creation of a direct financial obligation or off-balance sheet arrangement by incorporating Item 1.01 by reference. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. The reference to "off-balance sheet arrangement" suggests a material financial commitment, but the actual event type (potentially ma_activity, covenant_breach, or dilutive_issuance) depends on Item 1.01's details. Classified as other_material pending visibility into the underlying transaction.
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a clear disclosure of shareholder voting results from Ford Motor Company's Annual Meeting of Shareholders held on May 14, 2026, covering six proposals: director elections, auditor ratification, say-on-pay advisory vote, recapitalization plan, voting disclosure, and DEI by-law amendment. Item 5.07 explicitly requires disclosure of shareholder vote results, and the detailed tabulation of votes for and against each proposal is the core content of this filing.
View raw filing on EDGAR →
Exec departure
confidence 95%
filed 2026-05-19
Item 5.02
David B. Mitchell, II, Chief Wholesale Banking Officer of F.N.B. Corporation, announced his intention to retire effective July 2, 2026. This is a clear departure of a named officer, making exec_departure the appropriate classification. The retirement of a C-suite executive responsible for wholesale banking operations is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →
Shareholder vote
confidence 95%
filed 2026-05-19
Item 5.07
This is a standard Item 5.07 disclosure of shareholder meeting results held on May 18, 2026. The filing reports voting outcomes on three matters: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent accountants, and a non-binding say-on-pay proposal that notably failed to receive majority support (4.4M for vs. 6.9M against). The failure of the executive compensation proposal is material to investors as it signals shareholder dissatisfaction with compensation practices.
View raw filing on EDGAR →
Dilutive issuance
confidence 92%
filed 2026-05-19
Item 1.01
Capital Southwest Corporation amended its at-the-market (ATM) offering program on May 19, 2026, increasing the maximum aggregate offering amount from $1.0 billion to $2.0 billion through sixth amendments to equity distribution agreements with four sales agents (Jefferies, Raymond James, Citizens Capital Markets, and B. Riley). This is a material dilutive issuance under Item 1.01, as it substantially expands the company's capacity to issue common stock and would materially affect shareholder equity and voting power.
View raw filing on EDGAR →
M&A activity
confidence 95%
filed 2026-05-19
Item 7.01
Analog Devices announced entry into a definitive agreement to acquire Empower Semiconductor, a provider of integrated voltage regulators and power management solutions. The transaction is material M&A activity expected to close in H2 2026, subject to Hart-Scott-Rondino antitrust clearance. This is a clear acquisition announcement that would materially affect investor assessment of the registrant's strategic direction and financial position.
View raw filing on EDGAR →
Exec Compensation
confidence 95%
filed 2026-05-19
Item 5.02
The disclosure reports stockholder approval of the 2026 Long-Term Incentive Plan at the May 13, 2026 Annual Meeting. This is a compensatory arrangement for officers and directors — a material equity incentive plan that affects executive compensation structure and potential dilution. The filing explicitly incorporates the plan description from the Proxy Statement (pages 80-92) and attaches the complete plan as an exhibit, confirming this is a formal plan adoption requiring disclosure under Item 5.02(e).
View raw filing on EDGAR →
Shareholder vote
confidence 98%
filed 2026-05-19
Item 5.07
This is a classic Item 5.07 disclosure of shareholder voting results from an Annual Meeting. The filing reports the outcomes of nine proposals including director elections, auditor ratification, executive compensation advisory vote, charter amendments, equity plan approval, and a stockholder proposal. The voting results are presented in tabular form with votes for, against, abstain, and broker non-votes for each matter, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
M&A activity
confidence 85%
filed 2026-05-18
Item 1.01
The filing discloses two material transactions under Item 1.01: (1) an intellectual property purchase agreement with Apollo Group Enterprises for acquisition of software platform IP assets in exchange for 1.5 million shares of Class A Common Stock, and (2) a private placement offering of 54.4 units (promissory notes and warrants) generating $1.36 million in gross proceeds. The IP acquisition constitutes a material acquisition of assets, while the private placement represents a dilutive equity issuance. The IP acquisition is the primary event disclosed in Item 1.01 and would materially affect investor assessment of the company's asset base and capital structure.
View raw filing on EDGAR →
Dilutive issuance
confidence 92%
filed 2026-05-18
Item 3.02
Item 3.02 discloses unregistered sales of equity securities under an IP Purchase Agreement and Subscription Agreement to accredited investors (Apollo and other investors) in reliance on Section 4(a)(2) and Regulation D Rule 506(b). This is a classic private placement of equity securities exempt from registration, which is material to investors as it signals capital raising and potential dilution to existing shareholders.
View raw filing on EDGAR →
Other material
confidence 65%
filed 2026-05-18
Item 7.01
The filing discloses an "IP Purchase Agreement" announced via press release on May 12, 2026, but the actual terms, parties, and financial impact are not detailed in the Item 7.01 disclosure itself—only a reference to the attached exhibit. This appears to be a material transaction (intellectual property acquisition), but without the substantive details in the prose, the most appropriate classification is "other_material" rather than "ma_activity," which typically requires clearer disclosure of acquisition terms and significance. The materiality is presumed given the company's decision to file an 8-K and issue a press release.
View raw filing on EDGAR →
Earnings release
confidence 98%
filed 2026-05-07
Item 2.02
The filing discloses quarterly financial results for Q1 2026 (quarter ended March 31, 2026) via a press release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which would materially affect a reasonable investor's assessment of the company's financial performance and condition.
View raw filing on EDGAR →
Earnings release
confidence 98%
filed 2026-04-30
Item 2.02
Apple issued a press release on April 30, 2026 disclosing financial results for its second fiscal quarter ended March 28, 2026, with the press release attached as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as quarterly financial results directly affect assessment of the company's operational performance and financial condition.
View raw filing on EDGAR →